SI20018A - Večvalentne soli piridostigmina in sorodnih spojin - Google Patents
Večvalentne soli piridostigmina in sorodnih spojin Download PDFInfo
- Publication number
- SI20018A SI20018A SI9720075A SI9720075A SI20018A SI 20018 A SI20018 A SI 20018A SI 9720075 A SI9720075 A SI 9720075A SI 9720075 A SI9720075 A SI 9720075A SI 20018 A SI20018 A SI 20018A
- Authority
- SI
- Slovenia
- Prior art keywords
- compound according
- anion
- compounds
- multivalent
- phosphate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3118696P | 1996-11-19 | 1996-11-19 | |
| PCT/US1997/020509 WO1998022458A1 (en) | 1996-11-19 | 1997-11-10 | Multivalent salts of pyridostigmine and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI20018A true SI20018A (sl) | 2000-02-29 |
Family
ID=21858083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9720075A SI20018A (sl) | 1996-11-19 | 1997-11-10 | Večvalentne soli piridostigmina in sorodnih spojin |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6211201B1 (cs) |
| EP (1) | EP0941224A4 (cs) |
| JP (1) | JP2001505561A (cs) |
| KR (1) | KR20000069028A (cs) |
| CN (1) | CN1237969A (cs) |
| AU (1) | AU717740B2 (cs) |
| BR (1) | BR9713112A (cs) |
| CA (1) | CA2271786A1 (cs) |
| CZ (1) | CZ172799A3 (cs) |
| HU (1) | HUP9904040A3 (cs) |
| IL (1) | IL129619A0 (cs) |
| NO (1) | NO992384L (cs) |
| NZ (1) | NZ335419A (cs) |
| PL (1) | PL333414A1 (cs) |
| SI (1) | SI20018A (cs) |
| SK (1) | SK64399A3 (cs) |
| WO (1) | WO1998022458A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002092003A2 (en) * | 2001-05-11 | 2002-11-21 | Bacaner Marvin B | Novel therapeutical quaternary ammonium compositions |
| KR20050088992A (ko) | 2002-10-07 | 2005-09-07 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 아난드아미드 가수분해 차단을 통한 불안감의 조절 |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| AU2015217221A1 (en) | 2014-02-13 | 2016-08-11 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| CN107854428A (zh) * | 2016-12-20 | 2018-03-30 | 成都医学院 | 一种溴吡斯的明糖浆剂及其制备方法 |
| AU2019207625A1 (en) | 2018-01-09 | 2020-07-30 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
| CN113277961B (zh) * | 2021-04-09 | 2023-05-09 | 深圳市新浩瑞医药科技有限公司 | 一种溴新斯的明的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692530A (en) * | 1967-03-07 | 1987-09-08 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4686293A (en) * | 1967-05-29 | 1987-08-11 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4672120A (en) * | 1967-07-03 | 1987-06-09 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4246416A (en) * | 1967-12-01 | 1981-01-20 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4677222A (en) * | 1968-01-22 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Army | Ketobenzylcarbamates |
| US5534623A (en) * | 1993-01-21 | 1996-07-09 | Du Pont (Uk) Limited | Process for preparing a polyunsaturated diazonium compounds |
-
1997
- 1997-11-10 NZ NZ335419A patent/NZ335419A/xx not_active IP Right Cessation
- 1997-11-10 HU HU9904040A patent/HUP9904040A3/hu unknown
- 1997-11-10 EP EP97954835A patent/EP0941224A4/en not_active Withdrawn
- 1997-11-10 PL PL97333414A patent/PL333414A1/xx unknown
- 1997-11-10 KR KR1019997004410A patent/KR20000069028A/ko not_active Application Discontinuation
- 1997-11-10 US US09/308,723 patent/US6211201B1/en not_active Expired - Lifetime
- 1997-11-10 WO PCT/US1997/020509 patent/WO1998022458A1/en not_active Application Discontinuation
- 1997-11-10 BR BR9713112-1A patent/BR9713112A/pt not_active IP Right Cessation
- 1997-11-10 AU AU62367/98A patent/AU717740B2/en not_active Ceased
- 1997-11-10 SI SI9720075A patent/SI20018A/sl not_active IP Right Cessation
- 1997-11-10 CA CA002271786A patent/CA2271786A1/en not_active Abandoned
- 1997-11-10 CN CN97199841A patent/CN1237969A/zh active Pending
- 1997-11-10 SK SK643-99A patent/SK64399A3/sk unknown
- 1997-11-10 IL IL12961997A patent/IL129619A0/xx unknown
- 1997-11-10 JP JP52371598A patent/JP2001505561A/ja active Pending
- 1997-11-10 CZ CZ991727A patent/CZ172799A3/cs unknown
-
1999
- 1999-05-18 NO NO992384A patent/NO992384L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK64399A3 (en) | 2000-05-16 |
| CZ172799A3 (cs) | 1999-10-13 |
| PL333414A1 (en) | 1999-12-06 |
| BR9713112A (pt) | 2000-04-11 |
| NO992384L (no) | 1999-07-16 |
| JP2001505561A (ja) | 2001-04-24 |
| AU717740B2 (en) | 2000-03-30 |
| WO1998022458A1 (en) | 1998-05-28 |
| NZ335419A (en) | 2000-05-26 |
| CA2271786A1 (en) | 1998-05-28 |
| IL129619A0 (en) | 2000-02-29 |
| NO992384D0 (no) | 1999-05-18 |
| EP0941224A4 (en) | 2000-01-12 |
| CN1237969A (zh) | 1999-12-08 |
| US6211201B1 (en) | 2001-04-03 |
| AU6236798A (en) | 1998-06-10 |
| HUP9904040A3 (en) | 2000-09-28 |
| KR20000069028A (ko) | 2000-11-25 |
| EP0941224A1 (en) | 1999-09-15 |
| HUP9904040A2 (hu) | 2000-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60035440T2 (de) | Verwendung von substituierten Pyridinopentaazamakrozyklen-Komplexen mit Superoxiddismutaseaktivität | |
| DE69822659T2 (de) | Formulierungen und Verfahren zur Verminderung der Toxizität von Anti-Neoplastischen Mitteln | |
| DE60209145T2 (de) | Pharmazeutische formulierungen mit platinderivaten | |
| DD221459A5 (de) | Verfahren zur herstellung von omeprazolsalzen | |
| SI20018A (sl) | Večvalentne soli piridostigmina in sorodnih spojin | |
| US5393909A (en) | Diamine platinum complexes as antitumor agents | |
| CH642261A5 (de) | Arzneipraeparat auf der basis eines salzes der acetylsalicylsaeure und einer basischen aminosaeure und verfahren zu seiner herstellung. | |
| DE3408362C2 (de) | Arzneimittel mit antineoplastischer Wirkung | |
| DE69713763T2 (de) | Binukleare platinkomplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese komplexe enthalten | |
| DE2923334A1 (de) | Verwendung von cyclopentadienylmetall-acido-komplexen bei der krebsbekaempfung und diese komplexe enthaltende arzneimittel | |
| DE10113185A1 (de) | Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex | |
| MXPA99004608A (en) | Multivalent salts of pyridostigmine and related compounds | |
| EP1401425B1 (de) | Metallorganisches antitumormittel | |
| DE10114222C1 (de) | Tumorhemmende Siliciumverbindungen, Verfahren zu ihrer Herstellung und deren Verwendung | |
| DE10138561B4 (de) | Tumorhemmende Cerverbindungen sowie deren Verwendung | |
| EP0054215B1 (de) | (8-(Dialkylaminoalkoxy)-coffein)-Platinkomplexe, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| WO1995020956A1 (en) | Anti-tumour medical preparation on the basis of carboplatin and the method of its production | |
| DD298052A5 (de) | Verwendung von alkylphosphorsaeure-verbindungen zur bekaempfung von psoriasis-erkrankungen | |
| DE19510229A1 (de) | Antimikrobiell und antineoplastisch wirkende Bismutverbindungen mit Tropolon-, Thiosemicarbazon- und Dithiocarbazonsäureesterverbindungen und diese enthaltende Arzneimittel | |
| DE2244265A1 (de) | Neue imidazolderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten | |
| EP1414830A1 (de) | Tumorhemmende lanthanverbindungen | |
| DE10116527C2 (de) | Tumorhemmende Galliumverbindungen, deren Verwendung als Arzneimittel sowie ein Arzneimittel, diese enthaltend | |
| DE2324633A1 (de) | 2-eckige klammer auf (1-benzylcyclopentyl)-imino eckige klammer zu -pyrrolidin, verfahren zu seiner herstellung und diese verbindung enthaltende therapeutische zubereitungen | |
| JPS61186392A (ja) | 金化合物 | |
| DE3390386T1 (de) | Antitumor-Mittel, Verfahren zur Tumor-Therapie und Verwendung zur Tumor-Therapie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date | ||
| KO00 | Lapse of patent |
Effective date: 20060731 |